Company: SRPT
Filing Date: 2025-03-03
Form Type: S-3ASR
Source: 0001193125-25-044088
Chunk: 0

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-03-03
Form: S-3ASR
Chunk 0
---
As filed with the Securities and Exchange Commission on March 3, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SAREPTA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)

| Delaware                        |     | 93-0797222            |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -I.R.S. Employer      
 Identification Number |

215 First Street Suite 415 Cambridge, MA 02142 (617) 274-4000 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Douglas S. Ingram President and Chief Executive Officer Sarepta Therapeutics, Inc. 215 First Street, Suite 415 Cambridge, Massachusetts 02142 (617) 274-4000 (Name and address, including zip code, and telephone number, including area code, of agent for service of process for registrant) With copies to: Paul M. Kinsella William J. Michener Ropes & Gray LLP Prudential Tower 800 Boylston St. Boston, Massachusetts 02199 (617) 951-7000 From time to time after this registration statement becomes effective (Approximate date of commencement of proposed sale to the public) If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒ If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant